Discover
AVTE
Aerovate Therapeutics, Inc.
9.80
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
timesize
| Ytd | ||
| 1y |
92.04
day range
96.95
2.63
52 week range
884.98
| Open | 93.10 | Prev Close | 9.80 | Low | 92.04 | High | 96.95 | Mkt Cap | 77.68M |
| Vol | 0.00 | Avg Vol | 7.99K | EPS | -59.50 | P/E | -0.05 | Forward P/E | -2.60 |
| Beta | 0.95 | Short Ratio | 0.98 | Inst. Own | 102.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 88.74 | 200-d Avg | 82.18 | 1yr Est | 2.33 |
| Income Statement | |||
| Operating Expenses | 3.39M | ||
| Selling, General and Administrative Expense | 3.39M | ||
| Operating Income | -3.39M | ||
| Net Income | -2.52M | ||
| Net Income Common Stock | -2.52M | ||
| Net Income Common Stock (USD) | -2.52M | ||
| Consolidated Income | -2.52M | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -2.52M | ||
| Earning Before Interest & Taxes (USD) | -2.52M | ||
| Weighted Average Shares | 28.99M | ||
| Weighted Average Shares Diluted | 28.99M | ||
| Balance Sheet | |||
| Cash and Equivalents | 44.22M | ||
| Cash and Equivalents (USD) | 44.22M | ||
| Investments | 31.99M | ||
| Investments Current | 31.99M | ||
| Current Assets | 77.37M | ||
| Property, Plant & Equipment Net | 160.00K | ||
| Total Assets | 77.53M | ||
| Debt Current | 312.00K | ||
| Total Debt | 312.00K | ||
| Current Liabilities | 2.42M | ||
| Total Liabilities | 2.49M | ||
| Accumulated Retained Earnings (Deficit) | -235.57M | ||
| Accumulated Other Comprehensive Income | 50.00K | ||
| Shareholders Equity | 75.05M | ||
| Shareholders Equity (USD) | 75.05M | ||
| Assets Non-Current | 160.00K | ||
| Total Debt (USD) | 312.00K | ||
| Liabilities Non-Current | 70.00K | ||
| Trade and Non-Trade Payables | 69.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 10.47M | ||
| Net Cash Flow from Investing | 12.85M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 12.85M | ||
| Net Cash Flow from Operations | -2.38M | ||
| Share Based Compensation | 1.19M | ||